| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |